{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:19:17Z","timestamp":1784647157907,"version":"3.55.0"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Atypical antipsychotics (AAPs)-induced sexual dysfunction (SD) is a frequent issue in clinical practice, often underestimated by clinicians and not extensively researched. The current study aimed to quantify the strength of association between the use of different AAPs and SD using real-world data from the FDA Adverse Event Reporting System (FAERS), as well as investigate the receptor mechanisms that are involved.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data from the FAERS database from the first quarter of 2004 to the third quarter of 2023 were queried through OpenVigil 2.1. Disproportionality analysis was estimated using the reporting odds ratio (ROR) and information component (IC) methods, and linear regression was used to investigate the relationship between ROR and receptor occupancy which was estimated using <jats:italic>in vitro<\/jats:italic> receptor binding profiles.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our analysis yielded 4839 reports that co-mentioned AAP and SD events, and the findings revealed statistical associations between 12 AAPs and SD. The highest signal value was identified for iloperidone reporting retrograde ejaculation with iloperidone (ROR = 832.09, ROR<jats:sub>025<\/jats:sub> = 552.77; IC = 9.58, IC<jats:sub>025<\/jats:sub> = 6.36), followed by compulsive sexual behavior with aripiprazole (ROR = 533.02, ROR<jats:sub>025<\/jats:sub> = 435.90; IC = 7.30, IC<jats:sub>025<\/jats:sub> = 5.97), and psychosexual disorder for aripiprazole (ROR = 145.80, ROR<jats:sub>025<\/jats:sub> = 109.57; IC<jats:sub>025<\/jats:sub> = 6.47, IC025 = 4.86). Different characteristics of the SD side effects in each AAPs were discovered after further data mining. Regression analysis revealed potential effects for receptor occupancy of D2, D3, and 5-HT1A receptors on ROR. However, no significant correlation persisted following sensitivity analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This is the first study to investigate the AAP-SD associations by using FAERS. In this study, we report for the first time a significant association between aripiprazole and SD based on real-world data. The study suggests that different AAPs have varying levels of association with SD, and the D2, D3, and 5-HT1A receptor occupancy may contribute to potential mechanisms. The findings of this study warrant further validation of more studies and clinical causality assessment.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2024.1423075","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T04:38:03Z","timestamp":1720499883000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["The atypical antipsychotics and sexual dysfunction: a pharmacovigilance-pharmacodynamic study"],"prefix":"10.3389","volume":"15","author":[{"given":"Yu","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huafang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1037\/\/0735-7044.117.1.55","article-title":"Lack of opioid or dopaminergic effects on unconditioned sexual incentive motivation in male rats","volume":"117","author":"Agmo","year":"2003","journal-title":"Behav. Neurosci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/JCP.0b013e3181c8273d","article-title":"Priapism associated with antipsychotics: role of alpha1 adrenoceptor affinity","volume":"30","author":"Andersohn","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/pds.1742","article-title":"Quantitative signal detection using spontaneous ADR reporting","volume":"18","author":"Bate","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"B5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/713847170","article-title":"Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study","volume":"29","author":"Bobes","year":"2003","journal-title":"J. Sex. Marital Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nbt.2113","article-title":"OpenVigil--free eyeballs on AERS pharmacovigilance data","volume":"30","author":"Bohm","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"26650","DOI":"10.4088\/PCC.16l01983","article-title":"Aripiprazole-induced hypersexuality","volume":"18","author":"Bulbena-Cabr\u00e9","year":"2016","journal-title":"Prim. care companion CNS Disord."},{"key":"B8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/acps.13567","article-title":"Antipsychotics and obsessive-compulsive disorder\/obsessive-compulsive symptoms: a pharmacovigilance study of the FDA adverse event reporting system","volume":"148","author":"Burk","year":"2023","journal-title":"Acta Psychiatr. Scand."},{"key":"B9","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/schbul\/sbaa163","article-title":"Exploring a safety signal of antipsychotic-associated pneumonia: a pharmacovigilance-pharmacodynamic study","volume":"47","author":"Cepaityte","year":"2021","journal-title":"Schizophr. Bull."},{"key":"B10","doi-asserted-by":"publisher","first-page":"200","DOI":"10.4306\/pi.2013.10.2.200","article-title":"Two cases of hypersexuality probably associated with aripiprazole","volume":"10","author":"Cheon","year":"2013","journal-title":"Psychiatry Investig."},{"key":"B11","doi-asserted-by":"publisher","first-page":"102891","DOI":"10.1016\/j.ajp.2021.102891","article-title":"Selective serotonin reuptake inhibitors and manic switch: a pharmacovigilance and pharmacodynamical study","volume":"66","author":"\u00c7iray","year":"2021","journal-title":"Asian J. Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.psc.2016.04.006","article-title":"Sexual dysfunction due to psychotropic medications","volume":"39","author":"Clayton","year":"2016","journal-title":"Psychiatr. Clin. North Am."},{"key":"B13","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1093\/schbul\/sbv001","article-title":"The facts about sexual (Dys)function in schizophrenia: an overview of clinically relevant findings","volume":"41","author":"de Boer","year":"2015","journal-title":"Schizophr. Bull."},{"key":"B14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fnbeh.2020.00040","article-title":"Pharmacological studies on the role of 5-HT(1) (A) receptors in male sexual behavior of wildtype and serotonin transporter knockout rats","volume":"14","author":"Esquivel-Franco","year":"2020","journal-title":"Front. Behav. Neurosci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/pcn.13511","article-title":"Exploring the underlying mechanisms of drug\u2010induced impulse control disorders: a pharmacovigilance\u2010pharmacodynamic study","volume":"77","author":"Fusaroli","year":"2022","journal-title":"Psychiatry Clin. Neurosci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.drudis.2019.01.012","article-title":"Adverse drug reactions on sexual functioning: a systematic overview","volume":"24","author":"Gordijn","year":"2019","journal-title":"Drug Discov. Today"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.2165\/00003495-200464200-00003","article-title":"Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management","volume":"64","author":"Haddad","year":"2004","journal-title":"Drugs"},{"key":"B18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1471-244X-8-95","article-title":"The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913)","volume":"8","author":"Hanssens","year":"2008","journal-title":"BMC Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","first-page":"D1091","DOI":"10.1093\/nar\/gkx1121","article-title":"The IUPHAR\/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY","volume":"46","author":"Harding","year":"2018","journal-title":"Nucleic acids Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/clpt.2013.24","article-title":"Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system","volume":"93","author":"Harpaz","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/YIC.0b013e32833db3d8","article-title":"Tolerability of paliperidone: a meta-analysis of randomized, controlled trials","volume":"25","author":"Harrington","year":"2010","journal-title":"Int. Clin. Psychopharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1176\/appi.ps.201200183","article-title":"Prescription of second-generation antipsychotics: responding to treatment risk in real-world practice","volume":"64","author":"Hermes","year":"2013","journal-title":"Psychiatr. Serv."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1055\/s-0037-1600991","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1080\/14656566.2022.2071124","article-title":"Pharmacological strategies for sexual recovery in men undergoing antipsychotic treatment","volume":"23","author":"Jannini","year":"2022","journal-title":"Expert Opin. Pharmacother."},{"key":"B28","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.tips.2004.02.012","article-title":"Principles: receptor theory in pharmacology","volume":"25","author":"Kenakin","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/s0306-4530(02)00130-0","article-title":"What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning?","volume":"28","author":"Knegtering","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1055\/a-0941-3874","article-title":"Hypersexuality induced by aripiprazole","volume":"47","author":"Kozian","year":"2019","journal-title":"Psychiatr. Prax."},{"key":"B32","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1055\/s-0033-1347177","article-title":"Sexual dysfunction related to psychotropic drugs: a critical review part II: antipsychotics","volume":"46","author":"La Torre","year":"2013","journal-title":"Pharmacopsychiatry"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jamda.2023.09.029","article-title":"Antipsychotics in perspective: past, present, and future: article 1 of 3","volume":"25","author":"Levenson","year":"2024","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"B34","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3371\/csrp.MALA.123015","article-title":"Paliperidone palmitate-induced retrograde ejaculation","volume":"12","author":"Madan","year":"2018","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"key":"B35","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s40263-019-00631-5","article-title":"Association of hyponatraemia and antidepressant drugs: a pharmacovigilance\u2013pharmacodynamic assessment through an analysis of the US Food and drug administration adverse event reporting system (FAERS) database","volume":"33","author":"Mazhar","year":"2019","journal-title":"CNS Drugs"},{"key":"B36","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/pcn.13443","article-title":"Priapism and second-generation antipsychotics: disproportionality analysis of a spontaneous reporting system database in Japan","volume":"76","author":"Misawa","year":"2022","journal-title":"Psychiatry Clin. Neurosci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1210\/en.2006-1577","article-title":"Prolactin induces regional vasoconstriction through the beta2-adrenergic and nitric oxide mechanisms","volume":"148","author":"Molinari","year":"2007","journal-title":"Endocrinology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3390\/jcm10020308","article-title":"Management strategies for antipsychotic-related sexual dysfunction: a clinical approach","volume":"10","author":"Montejo","year":"2021","journal-title":"J. Clin. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1111\/j.1743-6109.2010.01709.x","article-title":"Frequency of sexual dysfunction in patients with a psychotic disorder receiving antipsychotics","volume":"7","author":"Montejo","year":"2010","journal-title":"J. Sex. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3389\/fpsyt.2019.00842","article-title":"Attitudes of Italian psychiatrists toward the evaluation of physical comorbidities and sexual dysfunction in patients with schizophrenia. Implications for clinical practice","volume":"10","author":"Monteleone","year":"2019","journal-title":"Front. Psychiatry"},{"key":"B41","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/labinvest.3700256","article-title":"Prolactin stimulates integrin-mediated adhesion of circulating mononuclear cells to endothelial cells","volume":"85","author":"Montes de Oca","year":"2005","journal-title":"Lab. Invest"},{"key":"B42","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/bcp.13145","article-title":"An original pharmacoepidemiological-pharmacodynamic method: application to antipsychotic-induced movement disorders","volume":"83","author":"Nguyen","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"CD008296","DOI":"10.1002\/14651858.CD008296.pub2","article-title":"Paliperidone palmitate for schizophrenia","author":"Nussbaum","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"B44","doi-asserted-by":"publisher","first-page":"153","DOI":"10.5534\/wjmh.2012.30.3.153","article-title":"Antipsychotic-induced sexual dysfunction and its management","volume":"30","author":"Park","year":"2012","journal-title":"World J. Men's Health"},{"key":"B45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/YIC.0000000000000168","article-title":"Reduced sexual dysfunction with aripiprazole once-monthly versus paliperidone palmitate: results from QUALIFY","volume":"32","author":"Potkin","year":"2017","journal-title":"Int. Clin. Psychopharmacol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s10549-020-06001-w","article-title":"Cyclin-dependent kinase 4\/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment","volume":"186","author":"Raschi","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"key":"B47","doi-asserted-by":"publisher","first-page":"451.e455","DOI":"10.1016\/j.genhosppsych.2014.03.011","article-title":"Priapism associated with iloperidone: a case report","volume":"36","author":"Rodriguez-Cabezas","year":"2014","journal-title":"General Hosp. Psychiatry"},{"key":"B48","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1177\/107385840000600408","article-title":"The multiplicity of serotonin receptors: uselessly diverse molecules or an embarrassment of riches?","volume":"6","author":"Roth","year":"2000","journal-title":"Neurosci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1097\/JCP.0b013e31818582de","article-title":"Aripiprazole induced hypersexuality in a 24-year-old female patient with schizoaffective disorder?","volume":"28","author":"Schlachetzki","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/YIC.0b013e328341e434","article-title":"A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics","volume":"26","author":"Serretti","year":"2011","journal-title":"Int. Clin. Psychopharmacol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2165\/00002018-200225060-00012","article-title":"Causal association in pharmacovigilance and pharmacoepidemiology: thoughts on the application of the Austin Bradford-Hill criteria","volume":"25","author":"Shakir","year":"2002","journal-title":"Drug Saf."},{"key":"B52","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2174\/1574886313666181026100000","article-title":"Novel adverse events of iloperidone: a disproportionality analysis in US Food and drug administration adverse event reporting system (FAERS) database","volume":"14","author":"Subeesh","year":"2019","journal-title":"Curr. Drug Saf."},{"key":"B53","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4103\/0019-5545.148532","article-title":"Sexual dysfunctions in schizophrenia: professionals and patients perspectives","volume":"57","author":"Tharoor","year":"2015","journal-title":"Indian J. Psychiatry"},{"key":"B54","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1600-0447.2009.01425.x","article-title":"Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies","volume":"121","author":"Verdoux","year":"2010","journal-title":"Acta Psychiatr. Scand."},{"key":"B55","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2515\/therapie\/2014064","article-title":"Hypersexuality associated with aripiprazole: a new case and review of the literature","volume":"69","author":"Vrignaud","year":"2014","journal-title":"Therapie"},{"key":"B56","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1517\/14740338.2016.1112376","article-title":"Sexual dysfunction related to antiepileptic drugs in patients with epilepsy","volume":"15","author":"Yang","year":"2016","journal-title":"Expert Opin. Drug Saf."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1423075\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T04:38:07Z","timestamp":1720499887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1423075\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,9]]},"references-count":51,"alternative-id":["10.3389\/fphar.2024.1423075"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1423075","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,9]]},"article-number":"1423075"}}